Interacciones de Clorotiazida

Clorotiazida (Diuril), diurético tiazídico, tiene 395 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 35; moderadas: 311; leves: 47; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 2. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (35)

  • Acetazolamidainhibidor de la anhidrasa carbónicaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • Ácido etacrínicodiurético de asaGrave

    CONTRAINDICATIONS All diuretics, including ethacrynic acid, are contraindicated in anuria. (etiqueta de Ácido etacrínico, Contraindicaciones)

  • Amiloridadiurético ahorrador de potasioGrave

    Hyperkalemia occurs commonly (about 10%) when amiloride is used without a kaliuretic diuretic. (etiqueta de Amilorida, Advertencia en recuadro)

  • Bicarbonato de sodioantiácidoGrave

    Sodium bicarbonate injection is contraindicated in patients who are losing chloride by vomiting or from continuous gastrointestinal suction and in patients receiving diuretics known to produce a hypochloremic alkalosis. (etiqueta de Bicarbonato de sodio, Contraindicaciones)

  • Brinzolamidainhibidor de la anhidrasa carbónicaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • Bumetanidadiurético de asaGrave

    WARNING Bumetanide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. (etiqueta de Bumetanida, Advertencia en recuadro)

  • CiclosporinainmunosupresorGrave

    Potassium-Sparing Diuretics Cyclosporine should not be used with potassium-sparing diuretics because hyperkalemia can occur. (etiqueta de Ciclosporina, Interacciones medicamentosas)

  • Citrato de potasiosuplemento de potasioGrave

    The following drug interactions may occur with potassium citrate: Potassium-sparing diuretics: concomitant administration should be avoided since the simultaneous administration of these agents can produce severe hyperkalemia (7.1) (etiqueta de Citrato de potasio, Interacciones medicamentosas)

  • ClozapinaantipsicóticoGrave

    Use CLOZARIL cautiously in patients with cardiovascular or cerebrovascular disease or conditions predisposing to hypotension (e.g., dehydration, use of antihypertensive medications) [see Dosage and Administration ( 2.2 , 2.6 ), Warnings and Precautions ( 5.2 )]. (etiqueta de Clozapina, Advertencia en recuadro)

  • Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (etiqueta de Coriogonadotropina alfa, Advertencias)

  • CONTRAINDICATIONS PROGLYCEM is contraindicated in patients with: Functional hypoglycemia Hypersensitivity to diazoxide, any of the excipients in PROGLYCEM, or other thiazides (etiqueta de Diazóxido, Contraindicaciones)

  • Diclorfenamidainhibidor de la anhidrasa carbónicaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • DofetilidaantiarrítmicoGrave

    In the DIAMOND trials, 1252 patients were treated with dofetilide and diuretics concomitantly, of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and diuretics. (etiqueta de Dofetilida, Interacciones medicamentosas)

  • Dorzolamidainhibidor de la anhidrasa carbónicaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • Dorzolamida y timololinhibidor de la anhidrasa carbónicaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • Droperidolantagonista de la dopaminaGrave

    Droperidol should be administered with extreme caution to patients who may be at risk for development of prolonged QT syndrome (e.g., congestive heart failure, bradycardia, use of a diuretic, cardiac hypertrophy, hypokalemia, hypomagnesemia, or administration of other drugs known to increase the QT interval). (etiqueta de Droperidol, Advertencia en recuadro)

  • Enalaprilatoinhibidor de la ECAGrave

    …sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include those with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. (etiqueta de Enalaprilato, Advertencias)

  • Eplerenonaantagonista de la aldosteronaGrave

    …• serum creatinine > 2.0 mg/dL in males or >1.8 mg/dL in females, • creatinine clearance < 50 mL/min, or • concomitant administration of potassium supplements or potassium-sparing diuretics (e.g., amiloride, spironolactone, or triamterene) [see Warnings and Precautions (5.1) , Adverse Reactions (6.2) , Drug Interactions (7) , and Clinical Pharmacology (12.3)… (etiqueta de Eplerenona, Contraindicaciones)

  • Eptifibatidaantiagregante plaquetarioGrave

    …of active abnormal bleeding within the previous 30 days Severe hypertension (systolic blood pressure >200 mm Hg or diastolic blood pressure >110 mm Hg) not adequately controlled on antihypertensive therapy Major surgery within the preceding 6 weeks History of stroke within 30 days or any history of hemorrhagic stroke Current or planned administration of another… (etiqueta de Eptifibatida, Contraindicaciones)

  • Because the use of diuretics can accentuate the diminished intravascular volume, diuretics should be avoided except in the late phase of resolution as described below. (etiqueta de Folitropina, Advertencias y precauciones)

  • GentamicinaaminoglucósidoGrave

    The concurrent use of gentamicin with potent diuretics, such as ethacrynic acid or furosemide, should be avoided, since certain diuretics by themselves may cause ototoxicity. (etiqueta de Gentamicina, Advertencia en recuadro)

  • Avoid diuretics or laxatives in patients with diarrhea. (etiqueta de Irinotecán, Advertencias y precauciones)

  • Itraconazolantifúngico azólicoGrave

    Diuretics Eplerenone Contraindicated during and 2 weeks after TOLSURA treatment. (etiqueta de Itraconazol, Interacciones medicamentosas)

  • Metazolamidainhibidor de la anhidrasa carbónicaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • Metolazonadiurético tiazídicoGrave

    Other Antihypertensive Drugs When metolazone tablets, USP, are used with other antihypertensive drugs, particular care must be taken to avoid excessive reduction of blood pressure, especially during initial therapy. (etiqueta de Metolazona, Advertencias)

  • MinoxidilvasodilatadorGrave

    Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents. (etiqueta de Minoxidil, Advertencia en recuadro)

  • NeomicinaaminoglucósidoGrave

    The concurrent use of neomycin with potent diuretics such as ethacrynic acid or furosemide should be avoided, since certain diuretics by themselves may cause ototoxicity. (etiqueta de Neomicina, Advertencia en recuadro)

  • Quinaprilinhibidor de la ECAGrave

    …sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include patients with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. (etiqueta de Quinapril, Advertencias)

  • SulfadiazinasulfonamidaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • Sulfadiazina de platasulfonamidaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • SulfasalazinasulfonamidaGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

  • Tadalafiloinhibidor de la PDE5Grave

    …coadministration of an alpha-blocker and CIALIS for the treatment of BPH has not been adequately studied, and due to the potential vasodilatory effects of combined use resulting in blood pressure lowering, the combination of CIALIS and alpha-blockers is not recommended for the treatment of BPH. [see Dosage and Administration ( 2.7 ), Drug Interactions ( 7.1 ),… (etiqueta de Tadalafilo, Advertencias y precauciones)

  • Trióxido de arsénicofármaco que prolonga el intervalo QTGrave

    The risk of torsade de pointes is related to the extent of QTc prolongation, concomitant administration of QTc prolonging drugs, a history of torsade de pointes, pre-existing QTc interval prolongation, congestive heart failure, administration of potassium-wasting diuretics, or other conditions that result in hypokalemia or hypomagnesemia. (etiqueta de Trióxido de arsénico, Advertencias y precauciones)

  • ZonisamidaanticonvulsivoGrave

    Hypersensitivity to this product or to other sulfonamide-derived drugs. (etiqueta de Clorotiazida, Contraindicaciones)

Interacciones moderadas (311)

  • AcarbosaantidiabéticoModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • AcebutololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Ácido acetilsalicílico y dipiridamolantiagregante plaquetarioModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Ácido mefenámicoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Ácido zoledrónicobisfosfonatoModerada

    Elderly patients and those receiving diuretic therapy are at increased risk of acute renal failure. (etiqueta de Ácido zoledrónico, Advertencias y precauciones)

  • AdrenalinasimpaticomiméticoModerada

    …Precautions (5.6) and Adverse Reactions (6) ]. β-blockers, such as propranolol Cyclopropane or halogenated hydrocarbon anesthetics, such as halothane Antihistamines Thyroid hormones Diuretics Cardiac glycosides, such as digitalis glycosides Quinidine Drugs potentiating hypokalemic effects of epinephrine • Potassium depleting diuretics • Corticosteroids • Theophylline… (etiqueta de Adrenalina, Interacciones medicamentosas)

  • AlcoholAlcoholModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • AlfuzosinaalfabloqueanteModerada

    Postural hypotension/syncope: Care should be taken in patients with symptomatic hypotension or who have had a hypotensive response to other medications or are concomitantly treated with antihypertensive medication or nitrates ( 5.1 ) (etiqueta de Alfuzosina, Advertencias y precauciones)

  • AliskirenoantihipertensivoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Alogliptinainhibidor de la DPP-4Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alogliptina y metforminainhibidor de la DPP-4Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alopurinolinhibidor de la xantina oxidasaModerada

    Hypersensitivity reactions to allopurinol tablets may be increased in patients with decreased kidney function receiving thiazide diuretics and allopurinol tablets concurrently. (etiqueta de Alopurinol, Advertencias y precauciones)

  • AmikacinaaminoglucósidoModerada

    Ethacrynic Acid, Furosemide, Urea, or Mannitol Some diuretics can enhance aminoglycoside toxicity by altering aminoglycoside concentrations in serum and tissue. (etiqueta de Amikacina, Interacciones medicamentosas)

  • AmiodaronaantiarrítmicoModerada

    Give special attention to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or in patients receiving concomitant diuretics and laxatives. (etiqueta de Amiodarona, Advertencias y precauciones)

  • Amlodipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Amlodipino y atorvastatinabloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Amlodipino y benazeprilbloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Amlodipino y olmesartánbloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Amlodipino y valsartánbloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Anfepramonaestimulante del SNCModerada

    The pressor effects of diethylpropion and those of other drugs may be additive when the drugs are used concomitantly; conversely, diethylpropion may interfere with antihypertensive drugs (i.e., guanethidine, a-methyldopa). (etiqueta de Anfepramona, Interacciones medicamentosas)

  • Arformoterolagonista beta-adrenérgicoModerada

    Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes. (etiqueta de Arformoterol, Interacciones medicamentosas)

  • AripiprazolantipsicóticoModerada

    Antihypertensive Drugs Due to its alpha-adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents. (etiqueta de Aripiprazol, Interacciones medicamentosas)

  • Armodafiniloestimulante del SNCModerada

    There was also a slightly greater proportion of patients on NUVIGIL requiring new or increased use of antihypertensive medications (2.9%) compared to patients on placebo (1.8%). (etiqueta de Armodafinilo, Advertencias y precauciones)

  • AsenapinaantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medications, patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), and patients… (etiqueta de Asenapina, Advertencias y precauciones)

  • AtenololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Atenolol y clortalidonabetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Atomoxetinainhibidor de la recaptación de noradrenalinaModerada

    Antihypertensive Drugs Prevention or Management Increase the frequency of monitoring blood pressure and adjust atomoxetine oral solution dosage as clinically appropriate. (etiqueta de Atomoxetina, Interacciones medicamentosas)

  • Avanafiloinhibidor de la PDE5Moderada

    • Use of avanafil with alpha-blockers, other antihypertensives, or substantial amounts of alcohol (greater than 3 units) may lead to hypotension ( 2.3 , 5.6 , 5.7 ) (etiqueta de Avanafilo, Advertencias y precauciones)

  • Azilsartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Baclofenorelajante muscularModerada

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Belladona y opioopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Benazeprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Benazepril e hidroclorotiazidainhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Benzfetaminaestimulante del SNCModerada

    Amphetamines may decrease the hypotensive effect of antihypertensives. (etiqueta de Benzfetamina, Interacciones medicamentosas)

  • BetaxololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Bexagliflozinainhibidor de SGLT2Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • BisoprololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Bisoprolol e hidroclorotiazidabetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • BortezomibModerada

    Hypotension: Use caution when treating patients taking antihypertensives, with a history of syncope, or with dehydration. (etiqueta de Bortezomib, Advertencias y precauciones)

  • BrexpiprazolantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medication), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (etiqueta de Brexpiprazol, Advertencias y precauciones)

  • Brimonidinaagonista alfa-adrenérgicoModerada

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (etiqueta de Brimonidina, Interacciones medicamentosas)

  • Brimonidina y timololagonista alfa-adrenérgicoModerada

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate/timolol maleate ophthalmic solution may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate/timolol maleate ophthalmic solution is advised. (etiqueta de Brimonidina y timolol, Interacciones medicamentosas)

  • Central Nervous System (CNS) depressants Antihistamines have additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, antianxiety agents, etc.). Antihypertensive drugs Sympathomimetic may reduce the effects of antihypertensive drugs. (etiqueta de Bromfeniramina, pseudoefedrina y dextrometorfano, Interacciones medicamentosas)

  • Bromocriptinaagonista de la dopaminaModerada

    Use caution in patients taking antihypertensive medications. (etiqueta de Bromocriptina, Advertencias y precauciones)

  • Budesonida y formoterolcorticosteroideModerada

    Diuretics: Use with caution. (etiqueta de Budesonida y formoterol, Interacciones medicamentosas)

  • BuprenorfinaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Butalbital y paracetamolbarbitúricoModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • ButorfanolopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Calcitriolanálogo de la vitamina DModerada

    Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (etiqueta de Calcitriol, Interacciones medicamentosas)

  • Canagliflozinainhibidor de SGLT2Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Candesartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Candesartán e hidroclorotiazidaantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Captoprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • CarbamazepinaanticonvulsivoModerada

    Elderly patients and patients treated with diuretics are at greater risk of developing hyponatremia. (etiqueta de Carbamazepina, Advertencias y precauciones)

  • CarbidopaModerada

    Symptomatic postural hypotension has occurred when carbidopa, given with levodopa or carbidopa-levodopa combination products, was added to the treatment of a patient receiving antihypertensive drugs. (etiqueta de Carbidopa, Interacciones medicamentosas)

  • Carbidopa y levodopafármaco dopaminérgicoModerada

    Antihypertensive drugs: May cause symptomatic postural hypotension. (etiqueta de Carbidopa y levodopa, Interacciones medicamentosas)

  • Carbidopa, levodopa y entacaponafármaco dopaminérgicoModerada

    Antihypertensive Agents Symptomatic postural hypotension has occurred when carbidopa/levodopa was added to the treatment of patients receiving antihypertensive drugs. (etiqueta de Carbidopa, levodopa y entacapona, Interacciones medicamentosas)

  • CariprazinaantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (etiqueta de Cariprazina, Advertencias y precauciones)

  • Carisoprodolrelajante muscularModerada

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • CarvedilolbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • CefepimacefalosporinaModerada

    Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (etiqueta de Cefepima, Interacciones medicamentosas)

  • CeftazidimacefalosporinaModerada

    Drug Interactions Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibacterial drugs or potent diuretics such as furosemide. (etiqueta de Ceftazidima, Interacciones medicamentosas)

  • CelecoxibAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Ciclobenzaprinarelajante muscularModerada

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • CiclofosfamidainmunosupresorModerada

    …inhibitors: ACE inhibitors can cause leukopenia. ● Natalizumab ● Paclitaxel: Increased hematotoxicity has been reported when cyclophosphamide was administered after paclitaxel infusion. ● Thiazide diuretics ● Zidovudine Increased cardiotoxicity ● Anthracyclines ● Cytarabine ● Pentostatin ● Radiation therapy of the cardiac region ● Trastuzumab Increased pulmonary toxicity… (etiqueta de Ciclofosfamida, Interacciones medicamentosas)

  • Increase the dose of diuretics as needed [see Adverse Reactions (6) ] . (etiqueta de Ciclosilicato de sodio y zirconio, Advertencias y precauciones)

  • CitalopramISRSModerada

    Elderly patients, patients taking diuretics, and those who are volume depleted may be at greater risk for developing hyponatremia with SSRIs [see Use in Specific Populations ( 8.5 )] . (etiqueta de Citalopram, Advertencias y precauciones)

  • ClofarabinaantimetabolitoModerada

    Consider use of diuretics and/or albumin. (etiqueta de Clofarabina, Advertencias y precauciones)

  • Clonidinaagonista alfa-adrenérgicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • ClorpromazinaantipsicóticoModerada

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (etiqueta de Clorpromazina, Precauciones)

  • Clortalidonadiurético tiazídicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Drugs That Increase the Risk of Hypercalcemia Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D). (etiqueta de Cloruro de calcio, Interacciones medicamentosas)

  • Clorzoxazonarelajante muscularModerada

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • CodeínaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Colestipolsecuestrador de ácidos biliaresModerada

    Studies in humans show that the absorption of chlorothiazide as reflected in urinary excretion is markedly decreased even when administered one hour before colestipol hydrochloride. (etiqueta de Colestipol, Interacciones medicamentosas)

  • Colestiraminasecuestrador de ácidos biliaresModerada

    Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (etiqueta de Colestiramina, Interacciones medicamentosas)

  • Dantrolenorelajante muscularModerada

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Dapagliflozinainhibidor de SGLT2Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Dapagliflozina y metforminainhibidor de SGLT2Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Desipraminaantidepresivo tricíclicoModerada

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with NORPRAMIN. (etiqueta de Desipramina, Advertencias)

  • DesmopresinaModerada

    …Hyponatremia Concomitant administration of DESMODA with other drugs that may increase the risk of water intoxication with hyponatremia, (e.g., tricyclic antidepressants, selective serotonin re-uptake inhibitors, chlorpromazine, opiate analgesics, thiazide diuretics, NSAIDs, lamotrigine, sulfonylureas, particularly chlorpropamide, oxybutynin and carbamazepine). (etiqueta de Desmopresina, Interacciones medicamentosas)

  • DesvenlafaxinaIRSNModerada

    Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk [see Use in Specific Populations (8.5) and Clinical Pharmacology (12.3) ] . (etiqueta de Desvenlafaxina, Advertencias y precauciones)

  • Dexlansoprazolinhibidor de la bomba de protonesModerada

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (etiqueta de Dexlansoprazol, Advertencias y precauciones)

  • Dexmetilfenidatoestimulante del SNCModerada

    • Antihypertensive Drugs: Monitor blood pressure. (etiqueta de Dexmetilfenidato, Interacciones medicamentosas)

  • DiclofenacoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • DiflunisalAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Digoxinaglucósido digitálicoModerada

    Serum potassium levels should be carefully monitored when digoxin is given to patients at high risk of hypokalemia ( e.g. , those receiving diuretics, corticosteroids, or other drugs that commonly lead to potassium loss; those with gastrointestinal losses through diarrhea, vomiting, or nasogastric suction; or those with potassium-losing endocrinopathies or nephropathies). (etiqueta de Digoxina, Advertencias y precauciones)

  • Diltiazembloqueador de los canales de calcioModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • DoxazosinaalfabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Doxercalciferolanálogo de la vitamina DModerada

    Risk may be increased when used concomitantly with high dose calcium preparations, thiazide diuretics, or vitamin D compounds. (etiqueta de Doxercalciferol, Advertencias y precauciones)

  • Drospirenona y etinilestradiolanticonceptivo oralModerada

    Medications that may increase serum potassium concentration include ACE inhibitors, angiotensin-II receptor antagonists, potassium-sparing diuretics, potassium supplementation, heparin, aldosterone antagonists, and NSAIDS. (etiqueta de Drospirenona y etinilestradiol, Advertencias y precauciones)

  • Dulaglutidaagonista del receptor de GLP-1Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • DuloxetinaIRSNModerada

    The risk of BP decreases may be greater in patients taking concomitant medications that induce orthostatic hypotension (such as antihypertensives) or are potent CYP1A2 inhibitors [see Drug Interactions ( 7.1 )] and in patients taking duloxetine delayed-release capsules at doses above 60 mg daily. (etiqueta de Duloxetina, Advertencias y precauciones)

  • EluxadolinaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Empagliflozinainhibidor de SGLT2Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Empagliflozina y metforminainhibidor de SGLT2Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Enalaprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Enalapril e hidroclorotiazidainhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Following initiation and titration of Epogen, approximately 25% of patients on dialysis required initiation of or increases in antihypertensive therapy; hypertensive encephalopathy and seizures have been reported in patients with CKD receiving Epogen. (etiqueta de Epoetina alfa, Advertencias y precauciones)

  • Epoprostenolanálogo de prostaglandinaModerada

    Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. (etiqueta de Epoprostenol, Interacciones medicamentosas)

  • EscitalopramISRSModerada

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk. (etiqueta de Escitalopram, Advertencias y precauciones)

  • EsmololbetabloqueanteModerada

    Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension. (etiqueta de Esmolol, Interacciones medicamentosas)

  • Esomeprazolinhibidor de la bomba de protonesModerada

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (etiqueta de Esomeprazol, Advertencias y precauciones)

  • Espironolactonaantagonista de la aldosteronaModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Espironolactona e hidroclorotiazidaantagonista de la aldosteronaModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • EtodolacoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Exenatidaagonista del receptor de GLP-1Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Felodipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Fenelzinainhibidor de la MAOModerada

    …hydrochloride desipramine hydrochloride imipramine hydrochloride doxepin carbamazepine cyclobenzaprine HCl amoxapine maprotiline HCl trimipramine maleate protriptyline HCl mirtazapine Phenelzine sulfate should be used with caution in combination with antihypertensive drugs, including thiazide diuretics and β-blockers, since exaggerated hypotensive effects may result. (etiqueta de Fenelzina, Advertencias)

  • FenobarbitalbarbitúricoModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • FenoprofenoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • FenoxibenzaminaalfabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • FentaniloopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Fentermina y topiramatoestimulante del SNCModerada

    In addition, when phentermine and topiramate extended-release capsules are used in conjunction with nonpotassium sparing diuretics this may further potentiate potassium-wasting. (etiqueta de Fentermina y topiramato, Advertencias y precauciones)

  • Fluconazolantifúngico azólicoModerada

    An effect of this magnitude should not necessitate a change in the fluconazole dose regimen in subjects receiving concomitant diuretics. (etiqueta de Fluconazol, Interacciones medicamentosas)

  • FludrocortisonacorticosteroideModerada

    Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (etiqueta de Fludrocortisona, Interacciones medicamentosas)

  • FluoxetinaISRSModerada

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk [see Use in Specific Populations ( 8.5 )] . (etiqueta de Fluoxetina, Advertencias y precauciones)

  • FlurbiprofenoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Fluticasona y salmeterolcorticosteroideModerada

    Diuretics: Use with caution. (etiqueta de Fluticasona y salmeterol, Interacciones medicamentosas)

  • FluvoxaminaISRSModerada

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk. (etiqueta de Fluvoxamina, Advertencias y precauciones)

  • Formoterolagonista beta-adrenérgicoModerada

    • Xanthine derivatives, steroids, diuretics, or non-potassium sparing diuretics may potentiate hypokalemia or ECG changes. (etiqueta de Formoterol, Interacciones medicamentosas)

  • FoscarnetantiviralModerada

    When diuretics are indicated, thiazides are recommended over loop diuretics because the latter inhibit renal tubular secretion, and may impair elimination of FOSCAVIR, potentially leading to toxicity. (etiqueta de Foscarnet, Interacciones medicamentosas)

  • Fosinoprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Fosinopril e hidroclorotiazidainhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Furosemidadiurético de asaModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • GlibenclamidasulfonilureaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Glibenclamida y metforminasulfonilureaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • GlimepiridasulfonilureaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • GlipizidasulfonilureaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Glipizida y metforminasulfonilureaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Guanfacinaagonista alfa-adrenérgicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • HaloperidolantipsicóticoModerada

    Caution is advised when haloperidol decanoate is used in combination with drugs known to cause electrolyte imbalance (e.g., diuretics or corticosteroids) because hypokalemia, hypomagnesemia, and hypocalcemia are risk factors for QT prolongation. (etiqueta de Haloperidol, Interacciones medicamentosas)

  • HidralazinavasodilatadorModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Hidroclorotiazidadiurético tiazídicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • HidrocodonaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • HidromorfonaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • IbuprofenoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • IloperidonaantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (etiqueta de Iloperidona, Advertencias y precauciones)

  • Imipraminaantidepresivo tricíclicoModerada

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with imipramine hydrochloride tablets. (etiqueta de Imipramina, Advertencias)

  • Indapamidadiurético tiazídicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • IndometacinaAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Insulina aspartainsulinaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Insulina degludecinsulinaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Insulina detemirinsulinaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Insulina glarginainsulinaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Insulina lisproinsulinaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Ipratropio y salbutamolanticolinérgicoModerada

    Diuretics The electrocardiogram (ECG) changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by β-agonists, especially when the recommended dose of the β-agonist is exceeded. (etiqueta de Ipratropio y salbutamol, Interacciones medicamentosas)

  • Irbesartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Irbesartán e hidroclorotiazidaantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Isradipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Ketoconazolantifúngico azólicoModerada

    Diuretics eplerenone The potential increase in plasma concentrations of eplerenone when coadministered with ketoconazole tablets may increase the risk of hyperkalemia and hypotension. (etiqueta de Ketoconazol, Interacciones medicamentosas)

  • KetoprofenoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • KetorolacoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • LabetalolbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Lansoprazolinhibidor de la bomba de protonesModerada

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (etiqueta de Lansoprazol, Advertencias y precauciones)

  • LevomilnacipránIRSNModerada

    Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk. (etiqueta de Levomilnaciprán, Advertencias y precauciones)

  • LevorfanolopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Levosalbutamolagonista beta-adrenérgicoModerada

    Diuretics The ECG changes or hypokalemia that may result from the administration of non-potassium-sparing diuretics (such as loop and thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded. (etiqueta de Levosalbutamol, Interacciones medicamentosas)

  • Linagliptinainhibidor de la DPP-4Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Linagliptina y metforminainhibidor de la DPP-4Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • LinezolidantibióticoModerada

    Monitor serum sodium levels regularly in the elderly, in patients taking diuretics, and in other patients at risk of hyponatremia and/or SIADH while taking Linezolid injection. (etiqueta de Linezolid, Advertencias y precauciones)

  • Liraglutidaagonista del receptor de GLP-1Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Lisinoprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Lisinopril e hidroclorotiazidainhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Litiofármaco serotoninérgicoModerada

    Lithium generally should not be given with diuretics (see PRECAUTIONS , Drug Interactions ). (etiqueta de Clorotiazida, Advertencias)

  • Lofexidinaagonista alfa-adrenérgicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Losartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Losartán e hidroclorotiazidaantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • LumateperonaantipsicóticoModerada

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive drugs), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and patients… (etiqueta de Lumateperona, Advertencias y precauciones)

  • LurasidonaantipsicóticoModerada

    Patients at increased risk of these adverse reactions or at increased risk of developing complications from hypotension include those with dehydration, hypovolemia, treatment with antihypertensive medication, history of cardiovascular disease (e.g., heart failure, myocardial infarction, ischemia, or conduction abnormalities), history of cerebrovascular disease,… (etiqueta de Lurasidona, Advertencias y precauciones)

  • MecamilaminaantihipertensivoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • MeloxicamAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • MetadonaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Metaxalonarelajante muscularModerada

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • MetforminabiguanidaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • MetildopaantihipertensivoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Metilfenidatoestimulante del SNCModerada

    Antihypertensive Drugs: Monitor blood pressure. (etiqueta de Metilfenidato, Interacciones medicamentosas)

  • Metocarbamolrelajante muscularModerada

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • MetohexitalbarbitúricoModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • MetoprololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Metoprolol e hidroclorotiazidabetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • MiglitolantidiabéticoModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • MilnacipránIRSNModerada

    Also, patients taking diuretics or who are otherwise volume-depleted may be at greater risk [see Geriatric Use ( 8.5 )] . (etiqueta de Milnaciprán, Advertencias y precauciones)

  • MirtazapinaantidepresivoModerada

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia [see Use in Specific Populations (8.5) ] . (etiqueta de Mirtazapina, Advertencias y precauciones)

  • Modafiniloestimulante del SNCModerada

    However, a retrospective analysis of the use of antihypertensive medication in these studies showed that a greater proportion of patients on PROVIGIL required new or increased use of antihypertensive medications (2.4%) compared to patients on placebo (0.7%). (etiqueta de Modafinilo, Advertencias y precauciones)

  • Moexiprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • MorfinaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • NabumetonaAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • NadololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • NalbufinaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • NaproxenoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • NateglinidameglitinidaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • NebivololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • NiacinaModerada

    Antihypertensive Therapy Niacin may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension. (etiqueta de Niacina, Interacciones medicamentosas)

  • Nicardipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Nifedipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Nimodipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Blood Pressure Lowering Drugs Nimodipine may increase the blood pressure lowering effect of concomitantly administered anti-hypertensives such as diuretics, beta-blockers, ACE inhibitors, angiotensin receptor blockers, other calcium channel blockers, α-adrenergic blockers, PDE5 inhibitors, and α-methyldopa. (etiqueta de Nimodipino, Interacciones medicamentosas)

  • Nisoldipinobloqueador de los canales de calcio dihidropiridínicoModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • NitroglicerinanitratoModerada

    Antihypertensives: Possible additive hypotensive effects. (etiqueta de Nitroglicerina, Interacciones medicamentosas)

  • NitroprusiatovasodilatadorModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • OlanzapinaantipsicóticoModerada

    …of myocardial infarction or ischemia, heart failure, or conduction abnormalities), cerebrovascular disease, and conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications) where the occurrence of syncope, or hypotension and/or bradycardia might put the patient at increased medical risk. (etiqueta de Olanzapina, Advertencias y precauciones)

  • Olanzapina y fluoxetinaantipsicóticoModerada

    …and fluoxetine capsules should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemia, heart failure, or conduction abnormalities), cerebrovascular disease, or conditions that would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (etiqueta de Olanzapina y fluoxetina, Advertencias y precauciones)

  • OliceridinaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Olmesartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Olmesartán e hidroclorotiazidaantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Olmesartán, amlodipino e hidroclorotiazidaantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Omeprazolinhibidor de la bomba de protonesModerada

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions ( 6.2 )] . (etiqueta de Omeprazol, Advertencias y precauciones)

  • Omeprazol y bicarbonato de sodioinhibidor de la bomba de protonesModerada

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions ( 6.2 )] . (etiqueta de Omeprazol y bicarbonato de sodio, Advertencias y precauciones)

  • Orfenadrinarelajante muscularModerada

    Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine) - possible increased responsiveness to the muscle relaxant. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • OxaprozinaAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • OxicodonaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • OximorfonaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • PaliperidonaantipsicóticoModerada

    Use ERZOFRI with caution in patients with known cardiovascular disease (e.g., heart failure, history of myocardial infarction or ischemia, conduction abnormalities), cerebrovascular disease, or conditions that predispose the patient to hypotension (e.g., dehydration, hypovolemia, and treatment with antihypertensive medications). (etiqueta de Paliperidona, Advertencias y precauciones)

  • Pantoprazolinhibidor de la bomba de protonesModerada

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ]. (etiqueta de Pantoprazol, Advertencias y precauciones)

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Paracetamol y codeínaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Paricalcitolanálogo de la vitamina DModerada

    The risk may be increased when Paricalcitol Injection is used concomitantly with high dose calcium preparations, thiazide diuretics, or vitamin D compounds. (etiqueta de Paricalcitol, Advertencias y precauciones)

  • ParoxetinaISRSModerada

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SNRIs and SSRIs. [see Use in Specific Populations ( 8.5 )]. (etiqueta de Paroxetina, Advertencias y precauciones)

  • PazopanibModerada

    Monitor blood pressure as clinically indicated and initiate and adjust antihypertensive therapy as appropriate. (etiqueta de Pazopanib, Advertencias y precauciones)

  • Pentazocina y naloxonaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • PentoxifilinametilxantinaModerada

    Small decreases in blood pressure have been observed in some patients treated with pentoxifylline extended-release tablets; periodic systemic blood pressure monitoring is recommended for patients receiving concomitant antihypertensive therapy. (etiqueta de Pentoxifilina, Interacciones medicamentosas)

  • Perindoprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Petidina (meperidina)opioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • PindololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • PioglitazonatiazolidinedionaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Pioglitazona y glimepiridatiazolidinedionaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Pioglitazona y metforminatiazolidinedionaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • PiroxicamAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • PrazosinaalfabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • PrimidonaanticonvulsivoModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • ProclorperazinaantipsicóticoModerada

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (etiqueta de Proclorperazina, Precauciones)

  • Prometazina y codeínaopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • PropranololbetabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • QuetiapinaantipsicóticoModerada

    Quetiapine should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), cerebrovascular disease, or conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (etiqueta de Quetiapina, Advertencias y precauciones)

  • Quinapril e hidroclorotiazidainhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • QuinidinaantiarrítmicoModerada

    Drugs that alkalinize the urine ( carbonic-anhydrase inhibitors, sodium bicarbonate, thiazide diuretics ) reduce renal elimination of quinidine. (etiqueta de Quinidina, Interacciones medicamentosas)

  • Rabeprazolinhibidor de la bomba de protonesModerada

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ]. (etiqueta de Rabeprazol, Advertencias y precauciones)

  • Ramiprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • RemifentaniloopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • RepaglinidameglitinidaModerada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • RiociguatvasodilatadorModerada

    Consider the potential for symptomatic hypotension or ischemia in patients with hypovolemia, severe left ventricular outflow obstruction, resting hypotension, autonomic dysfunction, or concomitant treatment with antihypertensives or strong CYP and P-gp/BCRP inhibitors [see Drug Interactions (7.2) and Clinical Pharmacology (12.3) ] . (etiqueta de Riociguat, Advertencias y precauciones)

  • RisperidonaantipsicóticoModerada

    Clinically significant hypotension has been observed with concomitant use of oral RISPERDAL and antihypertensive medication. (etiqueta de Risperidona, Advertencias y precauciones)

  • Sacubitrilo y valsartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Salbutamolagonista beta-adrenérgicoModerada

    Diuretics: Use with caution. (etiqueta de Salbutamol, Interacciones medicamentosas)

  • Salmeterolagonista beta-adrenérgicoModerada

    • Diuretics: Use with caution. (etiqueta de Salmeterol, Interacciones medicamentosas)

  • SalsalatoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Saxagliptinainhibidor de la DPP-4Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Saxagliptina y metforminainhibidor de la DPP-4Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Semaglutidaagonista del receptor de GLP-1Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • SertralinaISRSModerada

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs [see Use in Specific Populations ( 8.5 )] . (etiqueta de Sertralina, Advertencias y precauciones)

  • Sildenafiloinhibidor de la PDE5Moderada

    Caution is advised when SILDENAFIL ORAL FILM is co-administered with alpha-blockers or antihypertensives. (etiqueta de Sildenafilo, Advertencias y precauciones)

  • SilodosinaalfabloqueanteModerada

    However, patients in the Phase 3 clinical studies taking concomitant antihypertensive medications with silodosin capsules did not experience a significant increase in the incidence of syncope, dizziness, or orthostasis. (etiqueta de Silodosina, Advertencias y precauciones)

  • Sitagliptinainhibidor de la DPP-4Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Sitagliptina y metforminainhibidor de la DPP-4Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • SorafenibModerada

    Consider temporary or permanent discontinuation for severe or persistent hypertension despite antihypertensive therapy. (etiqueta de Sorafenib, Advertencias y precauciones)

  • SotalolbetabloqueanteModerada

    Special attention should be given to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or patients receiving concomitant diuretic drugs. (etiqueta de Sotalol, Advertencias y precauciones)

  • SulindacoAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Sumatriptán y naproxenotriptánModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • SunitinibModerada

    Initiate and/or adjust antihypertensive therapy as appropriate. (etiqueta de Sunitinib, Advertencias y precauciones)

  • Suxametonio (succinilcolina)bloqueador neuromuscularModerada

    Prolonged Neuromuscular Block in Patients with Hypokalemia or Hypocalcemia Neuromuscular blockade may be prolonged in patients with hypokalemia (e.g., after severe vomiting, diarrhea, digitalisation and diuretic therapy) or hypocalcemia (e.g., after massive transfusions). (etiqueta de Suxametonio (succinilcolina), Advertencias y precauciones)

  • TacrolimusinmunosupresorModerada

    • Hypertension: May require antihypertensive therapy; monitor relevant drug interactions. (etiqueta de Tacrolimus, Advertencias y precauciones)

  • TapentadolopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Telmisartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Telmisartán e hidroclorotiazidaantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Telmisartán y amlodipinoantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • TerazosinaalfabloqueanteModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Terbutalinaagonista beta-adrenérgicoModerada

    Diuretics The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded. (etiqueta de Terbutalina, Precauciones)

  • TestosteronaandrógenoModerada

    In patients with hypertension on antihypertensive therapy, TLANDO increased the mean systolic/diastolic BP by 4.8/1.6 mm Hg from baseline. [see Adverse Reactions ( 6.1 )] . (etiqueta de Testosterona, Advertencias y precauciones)

  • Tirzepatidaagonista del receptor de GLP-1Moderada

    Antidiabetic Drugs (Oral Agents and Insulin) - dosage adjustment of the antidiabetic drug may be required. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Tizanidinarelajante muscularModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • TobramicinaaminoglucósidoModerada

    Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. (etiqueta de Tobramicina, Interacciones medicamentosas)

  • TolmetinaAINEModerada

    Non-steroidal Anti-inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 (COX-2) Inhibitors - In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • TolvaptánModerada

    Co-administration of diuretics also increases the risk of too rapid correction of serum sodium and such patients should undergo close monitoring of serum sodium. (etiqueta de Tolvaptán, Advertencias y precauciones)

  • Torasemidadiurético de asaModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Toremifenomodulador selectivo de los receptores de estrógenosModerada

    Drugs that decrease renal calcium excretion, e.g., thiazide diuretics, may increase the risk of hypercalcemia in patients receiving FARESTON. (etiqueta de Toremifeno, Interacciones medicamentosas)

  • TramadolopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Tramadol y paracetamolopioideModerada

    Alcohol, Barbiturates, or Narcotics - potentiation of orthostatic hypotension may occur. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Trandolaprilinhibidor de la ECAModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • TrazodonaantidepresivoModerada

    Concomitant use with an antihypertensive may require a reduction in the dose of the antihypertensive drug. (etiqueta de Trazodona, Advertencias y precauciones)

  • Triamterenodiurético ahorrador de potasioModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Triamtereno e hidroclorotiazidadiurético ahorrador de potasioModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • TrifluoperazinaantipsicóticoModerada

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (etiqueta de Trifluoperazina, Precauciones)

  • Umeclidinio y vilanterolanticolinérgicoModerada

    • Diuretics: Use with caution. (etiqueta de Umeclidinio y vilanterol, Interacciones medicamentosas)

  • Valsartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Valsartán e hidroclorotiazidaantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • Vardenafiloinhibidor de la PDE5Moderada

    Vardenafil hydrochloride tablets can potentiate the hypotensive effects of nitrates, alpha- blockers, and antihypertensives. (etiqueta de Vardenafilo, Interacciones medicamentosas)

  • VenlafaxinaIRSNModerada

    Also, patients taking diuretics or who are otherwise volume-depleted may be at greater risk [see Use in Specific Populations ( 8.5 )] . (etiqueta de Venlafaxina, Advertencias y precauciones)

  • Verapamilobloqueador de los canales de calcioModerada

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (etiqueta de Clorotiazida, Advertencias)

  • VilazodonaISRSModerada

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs and SNRIs [see Use in Specific Populations ( 8.5 )] . (etiqueta de Vilazodona, Advertencias y precauciones)

  • Vitamina DVitaminas y mineralesModerada

    Los diuréticos tiazídicos reducen la excreción de calcio; combinados con suplementos de vitamina D y de calcio, esto puede llevar a hipercalcemia, sobre todo en adultos mayores. (NIH Office of Dietary Supplements, Vitamin D)

  • VortioxetinaantidepresivoModerada

    Also, patients taking diuretics or who are otherwise volume-depleted can be at greater risk. (etiqueta de Vortioxetina, Advertencias y precauciones)

  • Concurrent use with potassium-containing medications, potassium-sparing diuretics and angiotensin-converting enzyme inhibitors (ACE inhibitors) may result in hyperkalemia and cardiac arrhythmias or cardiac arrest. (etiqueta de Yoduro de potasio, Interacciones medicamentosas)

  • ZiprasidonaantipsicóticoModerada

    Hypokalemia may result from diuretic therapy, diarrhea, and other causes. (etiqueta de Ziprasidona, Advertencias y precauciones)

Menciones leves (47)

  • Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (etiqueta de Ambrisentán, Advertencias y precauciones)

  • Azelastina y fluticasonaantihistamínicoLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • BeclometasonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • BetametasonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Bosentáninductor de CYP3A4Leve

    Patients required intervention with a diuretic, fluid management, or hospitalization for decompensating heart failure. (etiqueta de Bosentán, Advertencias y precauciones)

  • BudesonidacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • CalcioVitaminas y mineralesLeve

    Los diuréticos tiazídicos reducen la excreción de calcio, por lo que una ingesta alta de calcio puede elevar el calcio en sangre. (NIH Office of Dietary Supplements, Calcium)

  • CiclesonidacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • ClobetasolcorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Acthar Gel may accentuate the electrolyte loss associated with diuretic therapy. (etiqueta de Corticotropina, Interacciones medicamentosas)

  • Fluid retention events were typically managed by supportive care measures that may include diuretics or short courses of steroids. (etiqueta de Dasatinib, Advertencias y precauciones)

  • DeflazacortcorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Desogestrel y etinilestradiolanticonceptivo oralLeve

    If other contraceptive methods are not suitable, hormonal contraceptive therapy may continue combined with antihypertensive therapy. (etiqueta de Desogestrel y etinilestradiol, Advertencias)

  • DesonidacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • DexametasonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Dexanfetaminaestimulante del SNCLeve

    Examples of alkalinizing agents include gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) and urinary alkalinizing agents (e.g. acetazolamide, some thiazides). (etiqueta de Dexanfetamina, Interacciones medicamentosas)

  • Patients developing peripheral edema may be treated with standard measures, e.g., salt restriction, oral diuretic(s). (etiqueta de Docetaxel, Advertencias y precauciones)

  • DronedaronaantiarrítmicoLeve

    Hypokalemia and Hypomagnesemia with Potassium-Depleting Diuretics Hypokalemia or hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. (etiqueta de Dronedarona, Advertencias y precauciones)

  • EfedrinasimpaticomiméticoLeve

    Examples: α-adrenergic antagonists, β-adrenergic receptor antagonists, reserpine, quinidine, mephentermine Other Drug Interactions G u anethidine C linical Impact: Ephedrine may inhibit the neuron blockage produced by guanethidine, resulting in loss of antihypertensive effectiveness. (etiqueta de Efedrina, Interacciones medicamentosas)

  • In addition to discontinuation of the drug, diuretic therapy may be required. (etiqueta de Estrógenos esterificados y metiltestosterona, Advertencias)

  • Finasteridainhibidor de la 5-alfa reductasaLeve

    …clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives… (etiqueta de Finasterida, Interacciones medicamentosas)

  • FlecainidaantiarrítmicoLeve

    Flecainide acetate has been used in a large number of patients receiving diuretics without apparent interaction. (etiqueta de Flecainida, Interacciones medicamentosas)

  • FlunisolidacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • FluocinonidacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • FluticasonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Drugs that may cause hypercalcemia: Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. (etiqueta de Gluconato de calcio, Interacciones medicamentosas)

  • HalobetasolcorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • HidrocortisonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • ACE Inhibitors FIRAZYR is a bradykinin B2 receptor antagonist and thereby has the potential to have a pharmacodynamic interaction with ACE inhibitors where FIRAZYR may attenuate the antihypertensive effect of ACE inhibitors. (etiqueta de Icatibant, Interacciones medicamentosas)

  • Imatinibinhibidor de CYP3A4Leve

    Weigh patients regularly and manage unexpected rapid weight gain by drug interruption and diuretics. (etiqueta de Imatinib, Advertencias y precauciones)

  • Postmarketing cases of edema and fluid retention occurring within weeks of starting OPSUMIT, some requiring intervention with a diuretic or hospitalization for decompensated heart failure, have been reported [see Adverse Reactions (6.2) ] . (etiqueta de Macitentán, Advertencias y precauciones)

  • MagnesioVitaminas y mineralesLeve

    El uso a largo plazo de diuréticos de asa y diuréticos tiazídicos aumenta la pérdida de magnesio por la orina. (NIH Office of Dietary Supplements, Magnesium)

  • MetilprednisolonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • MetiltestosteronaandrógenoLeve

    In addition to discontinuation of the drug, diuretic therapy may be required. (etiqueta de Metiltestosterona, Advertencias)

  • MexiletinaantiarrítmicoLeve

    In a large compassionate use program mexiletine has been used concurrently with commonly employed antianginal, antihypertensive, and anticoagulant drugs without observed interactions. (etiqueta de Mexiletina, Interacciones medicamentosas)

  • MometasonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Nortriptilinaantidepresivo tricíclicoLeve

    The antihypertensive action of guanethidine and similar agents may be blocked. (etiqueta de Nortriptilina, Advertencias)

  • Olopatadina y mometasonaantihistamínicoLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Penicilina Gantibiótico del grupo de las penicilinasLeve

    These drugs include: aspirin, phenylbutazone, sulfonamides, indomethacin, thiazide diuretics, furosemide and ethacrynic acid. (etiqueta de Penicilina G, Interacciones medicamentosas)

  • Piperacilina y tazobactamantibiótico del grupo de las penicilinasLeve

    Periodic electrolyte determinations should be performed in patients with low potassium reserves, and the possibility of hypokalemia should be kept in mind with patients who have potentially low potassium reserves and who are receiving cytotoxic therapy or diuretics. (etiqueta de Piperacilina y tazobactam, Advertencias y precauciones)

  • PotasioVitaminas y mineralesLeve

    Los diuréticos de asa y los diuréticos tiazídicos aumentan la pérdida de potasio; a veces se prescribe un suplemento junto con ellos. (NIH Office of Dietary Supplements, Potassium)

  • PrednisolonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • PrednisonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • Protriptilinaantidepresivo tricíclicoLeve

    Protriptyline may block the antihypertensive effect of guanethidine or similarly acting compounds. (etiqueta de Protriptilina, Advertencias)

  • TerbinafinaantifúngicoLeve

    There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, phenytoins, thiazide diuretics, and calcium channel blockers. (etiqueta de Terbinafina, Interacciones medicamentosas)

  • TriamcinolonacorticosteroideLeve

    Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. (etiqueta de Clorotiazida, Interacciones medicamentosas)

  • ZincVitaminas y mineralesLeve

    Los diuréticos tiazídicos aumentan la pérdida de zinc por la orina con el uso a largo plazo. (NIH Office of Dietary Supplements, Zinc)

Sin interacción significativa según la etiqueta (2)

  • PamidronatobisfosfonatoSin interacción

    Loop Diuretics Concomitant administration of a loop diuretic had no effect on the calcium-lowering action of pamidronate disodium. (etiqueta de Pamidronato, Interacciones medicamentosas)

  • Ropinirolagonista de la dopaminaSin interacción

    Commonly Administered Drugs: Population analysis showed that commonly administered drugs (e.g., selegiline, amantadine, tricyclic antidepressants, benzodiazepines, ibuprofen, thiazides, antihistamines, anticholinergics) did not affect the clearance of ropinirole. (etiqueta de Ropinirol, Interacciones medicamentosas)

Compruebe Clorotiazida frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.